Cargando…
Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature
OBJECTIVE: The aim of this current report was to present a critical review of the use of cannabidiol (CBD) in the treatment of refractory epilepsies in the pediatric population. DATA SOURCE: Literature review was carried out in the Medline (PubMed), Cochrane, and Scientific Electronic Library Online...
Autores principales: | Moreira, Gabriela Araujo, Moraes, Roddie, Ribeiro, Ricardo Gullit, Crippa, Ana Chrystina De Souza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade de Pediatria de São Paulo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273119/ https://www.ncbi.nlm.nih.gov/pubmed/35830160 http://dx.doi.org/10.1590/1984-0462/2023/41/2021197 |
Ejemplares similares
-
Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016) -
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020) -
Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021) -
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
por: Gómez, Claudia Taborda, et al.
Publicado: (2021) -
Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)